CLINICAL_TRIALS
trial_result
· 2010-08-16
Clinical Trial Update: Liposomal Doxorubicin in Treating Patients With Prostate Cancer [Phase 2]
Summary
A Phase 2 trial evaluating liposomal doxorubicin for patients with prostate cancer has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Case Comprehensive Cancer Center | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED